Company overview
Aarti Drugs Limited
CIN
L37060MH1984PLC055433
Name
Aarti Drugs Limited
Entity type
Public
Paid up capital
₹912,700,000
Authorized capital
₹1,200,000,000
Industry name
Manufacturing (Others)
Registry
ROC Mumbai
Status
Active
Incorporation date
28 September 1984
Address
Plot No 198 Midc Tarapurtal.Palghar Village Pamtermbhi, , Dist Thane, Maharashtra
Postal code
401506
Country
India
Primary goods traded
- 34.2% — Amino-naphthols and other amino-phenols, other than those containing more than one kind of oxygen function, their ethers and esters (292229)
- 24.2% — Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 (293499)
- 18.7% — Heterocyclic compounds (293329)
- 11.8% — Nitrile-function compounds (292620)
- 11.0% — Ketones (291439)
Directors
| Name | DIN | Designation | Join Date | Resign Date |
|---|---|---|---|---|
| Gogri Rajendra Vallabhaji | 00061003 | Director | 29 September 1984 | 25 August 2020 |
| Satish Prabhakar Nachane | 00005520 | Managing Director | 5 January 1985 | 30 July 2007 |
| Harshit Manilal Savla | 00005340 | Managing Director | 2 January 1987 | |
| Krishnacharya Govindacharya Akamanchi | 02354032 | Director | 20 October 2008 | |
| Navin Chapshi Shah | 01415556 | Director | 4 November 2010 | |
| Prakash Moreshwar Patil | 00005618 | Managing Director | 5 January 1985 | |
| Ramdas Maneklal Gandhi | 00029437 | Director | 31 December 2005 | |
| Uday Moreshwar Patil | 01186406 | Wholetime Director | 18 October 2000 | |
| Bhavesh Rasiklal Vora | 00267604 | Director | 31 July 2006 | |
| Priti Paras Savla | 00662996 | Director | 26 September 2014 | |
| Rashesh Chandrakant Gogri | 00066291 | Managing Director | 16 August 2012 | |
| Vilas Gaikar Gajanan | 00033383 | Director | 31 December 2005 | |
| Shah Harit Pragji | 00005501 | Wholetime Director | 15 September 1995 | |
| Narendra Jagannath Salvi | 00299202 | Director | 25 August 2020 |
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Global Chemindo Megatrading | buyer | $7,564,123 | 4.01% |
| PT Tigaka Distrindo Perkasa | buyer | $6,953,667 | 3.68% |
| Adani Global Pte. Ltd. | seller | $3,716,914 | 1.97% |
| PT Dian Ciptaperkasa | buyer | $2,134,589 | 1.13% |
| PT Ferron Par Pharmaceuticals | buyer | $2,090,290 | 1.11% |
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 22 March 2022 | IN | 29222990 | Ethyl 3-(Cyclopropylamino) -2-(2,4-Dichloro-5-Fluorobenzoyl) Acrylate 99 Pct Min | Aarti Drugs Limited | IN | Fushine Taizhou Life Science | $1,256,000.00 | |
| 1 March 2022 | IN | 29222990 | Ethyl 3-(Cyclopropylamino) -2-(2,4-Dichloro-5-Fluorobenzoyl) Acrylate | Aarti Drugs Limited | IN | Zhejiang Medicines & Helath Pr | $1,252,000.00 | |
| 17 May 2022 | IN | 29222990 | Ethyl 3-(Cyclopropylamino) -2-(2,4-Dichloro-5-Fluorobenzoyl) Acrylate 99 Pct Min | Aarti Drugs Limited | IN | Fushine Taizhou Life Science | $1,004,800.00 | |
| 3 May 2022 | IN | 29222990 | Ethyl 3-(Cyclopropylamino) -2-(2,4-Dichloro-5-Fluorobenzoyl) Acrylate 99 Pct Min | Aarti Drugs Limited | IN | Fushine Taizhou Life Science | $1,004,800.00 | |
| 1 March 2022 | IN | 29222990 | Ethyl 3-(Cyclopropylamino) -2-(2,4-Dichloro-5-Fluorobenzoyl) Acrylate 99 Pct Min | Aarti Drugs Limited | IN | Fushine Taizhou Life Science | $1,004,800.00 | |
| 9 May 2022 | IN | 29222990 | Ethyl 3-(Cyclopropylamino) -2-(2,4-Dichloro-5-Fluorobenzoyl) Acrylate | Aarti Drugs Limited | IN | Zhejiang Ueasy Business Servic | $803,400.00 | |
| 15 April 2022 | IN | 29262000 | Dicyandiamide | Aarti Drugs Limited | IN | Ningxia Taikang Pharmaceuticals Co | $798,000.00 | |
| 13 August 2022 | IN | 29222990 | Ethyl 3-(Cyclopropylamino) -2-(2,4-Dichloro-5-Fluorobenzoyl) Acrylate 99 Pct Min | Aarti Drugs Limited | IN | Fushine Taizhou Life Science | $683,977.91 | |
| 17 September 2022 | IN | 29222990 | Ethyl 3-(Cyclopropylamino) -2-(2,4-Dichloro-5-Fluorobenzoyl) Acrylate 99 Pct Min | Aarti Drugs Limited | IN | Fushine Taizhou Life Science | $641,808.00 | |
| 19 September 2022 | IN | 29222990 | Ethyl 3-(Cyclopropylamino) -2-(2,4-Dichloro-5-Fluorobenzoyl) Acrylate 99 Pct Min | Aarti Drugs Limited | IN | Fushine Taizhou Life Science | $641,808.00 |
0 of 20 row(s) selected.